Kema Fund

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 17, 2022	Torigen Pharmaceuticals	$13.0M Series A	Connecticut Innovations, Musan Duric	Advantage Capital, Neil Cohen, Gaingels, Ironwood Capital, SoGal Ventures, UCONN Innovation Fund, University of Notre Dame

Total Raised

N/A

Valuation

N/A